Related Articles
Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review)
Histone deacetylase 2 is involved in µ‑opioid receptor suppression in the spinal dorsal horn in a rat model of chronic pancreatitis pain
FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression
Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation
Molecular insights into the benefits of nicotine on memory and cognition (Review)